Statistically significant improvements were shown 3 months vs. placebo with tofacitinib, in this new study
Your search for tofacitinib returned 2 results
Cycling to a different tumor necrosis factor alpha inhibitor (TNFi) after treatment failure in patients with rheumatoid arthritis (RA) can be effective.